The latest Reclast study emphasizes the importance of treating patients for osteoporosis after a hip fracture

The latest Reclast study emphasizes the importance of treating patients for osteoporosis after a hip fracture.

Elderly patients who break a hip have a high risk of disability, future fractures, and even death.

Now there's evidence that Reclast (zoledronic acid) reduces the risk of a second fracture and improves survival in these patients.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote